Diagnostic yield in families to sudden cardiac death victims: a 10-year follow-up study
- PMID: 40515685
- PMCID: PMC12264593
- DOI: 10.1093/europace/euaf119
Diagnostic yield in families to sudden cardiac death victims: a 10-year follow-up study
Abstract
Aims: Up to 70% of sudden cardiac death (SCD) cases in younger individuals are potentially caused by an inherited heart disease. However, long-term diagnostic yield and risk of cardiac events in SCD relatives remain unclear. This study aimed to determine the 10-year diagnostic yield of inherited heart diseases and frequency of cardiac events in SCD relatives.
Methods and results: This retrospective study included SCD probands and their relatives referred to the Unit for Inherited Heart Diseases at Rigshospitalet, Denmark, from 2005 to 2018. Relatives underwent guideline-recommended screening and follow-up. Diagnoses and cardiac events, such as new-onset reduced left ventricular ejection fraction ≤45%, sustained ventricular tachycardia, appropriate implantable cardioverter-defibrillator therapy, cardiac death, and (aborted) SCD, were registered. A total of 686 relatives (47% males, median baseline age 35 years) to 299 probands (75% males, median death age 41 years) were followed for a median of 10.6 years. At 10-year follow-up, 12% of relatives (n = 82) were diagnosed with an inherited heart disease, with 93% (n = 76) diagnosed within 5 years. Cardiac events occurred in 18 (3%) and 24 (4%) relatives after 5- and 10-year follow-up, respectively. Five (0.7%) relatives of probands with no established diagnosis, who had no diagnosis nor cardiac event within 5 years of follow-up, were diagnosed between >5 and 10 years of follow-up.
Conclusion: Long-term follow-up identified an inherited heart disease in 12% of SCD relatives, primarily diagnosed within 5 years. Cardiac events were rare (4%). These findings suggest that follow-up may be considered limited to 5 years for specific adult SCD relatives.
Keywords: Autopsy; Family screening; Genetic testing; Inherited heart disease; Prevention; Sudden cardiac death.
© The Author(s) 2025. Published by Oxford University Press on behalf of the European Society of Cardiology.
Conflict of interest statement
Conflict of interest: B.G.W.: Advisory board for Sanofi. J.T.-H.: Consultant for Johnson and Johnson, Boston Scientific, MicroPort, Solid Bioscience, Cytokinetics and Leo Pharma. C.M.H.: Research grants from TrygFonden, Laerdal Foundation, Helsefonden, Independent Research Fund Denmark, Novo Nordisk Foundation, Capital Region of Denmark Research Fund. ILCOR BLS Task Force member, steering committee member RACE-CARS trial and HeartRunner trial, primary investigator CARAMBA trial. All remaining authors have declared no conflicts of interest.
Figures



Comment in
-
Screening families after sudden cardiac death in the young: do we ever stop?Europace. 2025 Jul 1;27(7):euaf141. doi: 10.1093/europace/euaf141. Europace. 2025. PMID: 40667716 Free PMC article. No abstract available.
Similar articles
-
Implantable defibrillators versus medical therapy for cardiac channelopathies.Cochrane Database Syst Rev. 2015 Oct 7;2015(10):CD011168. doi: 10.1002/14651858.CD011168.pub2. Cochrane Database Syst Rev. 2015. PMID: 26445202 Free PMC article.
-
Risk factors for sudden cardiac death in childhood hypertrophic cardiomyopathy: A systematic review and meta-analysis.Eur J Prev Cardiol. 2017 Jul;24(11):1220-1230. doi: 10.1177/2047487317702519. Epub 2017 May 9. Eur J Prev Cardiol. 2017. PMID: 28482693
-
A review of the evidence on the effects and costs of implantable cardioverter defibrillator therapy in different patient groups, and modelling of cost-effectiveness and cost-utility for these groups in a UK context.Health Technol Assess. 2006 Aug;10(27):iii-iv, ix-xi, 1-164. doi: 10.3310/hta10270. Health Technol Assess. 2006. PMID: 16904046
-
Optimizing the Primary Prevention of Sudden Cardiac Death in Patients With Heart Failure.J Am Coll Cardiol. 2025 Aug 5;86(5):374-395. doi: 10.1016/j.jacc.2025.05.061. J Am Coll Cardiol. 2025. PMID: 40738564 Review.
-
Do gender differences persist in ICD implantation in patients with acute on chronic heart failure?Future Cardiol. 2025 May;21(6):365-370. doi: 10.1080/14796678.2025.2484958. Epub 2025 Mar 30. Future Cardiol. 2025. PMID: 40159103
Cited by
-
Screening families after sudden cardiac death in the young: do we ever stop?Europace. 2025 Jul 1;27(7):euaf141. doi: 10.1093/europace/euaf141. Europace. 2025. PMID: 40667716 Free PMC article. No abstract available.
References
-
- Lynge TH, Nielsen JL, Risgaard B, van der Werf C, Winkel BG, Tfelt-Hansen J. Causes of sudden cardiac death according to age and sex in persons aged 1–49 years. Heart Rhythm 2023;20:61–8. - PubMed
-
- Kumar A, Avishay DM, Jones CR, Shaikh JD, Kaur R, Aljadah M et al. Sudden cardiac death: epidemiology, pathogenesis and management. Rev Cardiovasc Med 2021;22:147–58. - PubMed
-
- Wong CX, Brown A, Lau DH, Chugh SS, Albert CM, Kalman JM et al. Epidemiology of sudden cardiac death: global and regional perspectives. Heart Lung Circ 2019;28:6–14. - PubMed
-
- Lynge TH, Risgaard B, Banner J, Nielsen JL, Jespersen T, Stampe NK et al. Nationwide burden of sudden cardiac death: a study of 54,028 deaths in Denmark. Heart Rhythm 2021;18:1657–65. - PubMed
-
- Jean-Philippe E, Lerner I, Valentin E, Folke F, Böttiger B, Gislason G et al. Incidence of sudden cardiac death in the European Union. J Am Coll Cardiol 2022;79:1818–27. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical